Anti-Aging, Longevity, Life Extension and Biotechnology Information
Anti-Aging, Longevity, Life Extension and Biotechnology Information
Anti-Aging Medicine, Anti-Ageing Medicine, Antiaging Medicine
Tools » Drug Information
Related Drug Reading

M2 Presswire - Statement on generic oxycodone hydrochloride extended release tablets.

March 24, 2004 -- M2 PRESSWIRE-24 March 2004-US FDA: Statement on generic oxycodone hydrochloride extended release tablets(C)1994-2004 M2 COMMUNICATIONS LTD...

Business Wire - Covidien Announces Agreement with Purdue Pharma L.P. Enabling Launch of Oxycodone Hydrochloride Extended-Release Tablets

September 2, 2008 -- MANSFIELD, Mass. -- Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced that its subsidiary,...

Business Wire - Teva Announces Tentative Approval of Oxycodone Hydrochloride ER Tablets, 80 mg

September 30, 2003 -- Business Editors/Health/Medical Writers JERUSALEM--(BUSINESS WIRE)--Sept. 30, 2003 Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced...

Business Wire - IMPAX Signs Exclusive Supply and Distribution Agreement with DAVA Pharmaceuticals for Oxycodone Hydrochloride Extended Release Tablets

November 7, 2005 -- HAYWARD, Calif. -- IMPAX Laboratories, Inc. (OTC:IPXL) announced today it has entered into a ten year Exclusive Supply and Distribution agreement...

Business Wire - Teva Announces Tentative Approval of Oxycodone Hydrochloride ER Tablets, 10 mg, 20 mg, and 40 mg

December 10, 2004 -- JERUSALEM -- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. Food and Drug Administration has granted tentative...

Business Wire - IMPAX Receives Final FDA Approval for Oxycodone Hydrochloride Controlled Release Tablets, 80mg; Tenth Approval in 2004

September 28, 2004 -- HAYWARD, Calif. -- IMPAX Laboratories, Inc. (Nasdaq:IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted final approval to...

Business Wire - Elite Pharmaceuticals Successfully Concludes Second Pilot Phase I Trial of Its Once-Daily Oxycodone Hydrochloride Product; Positive Results from Second...

June 27, 2006 -- NORTHVALE, N.J. -- Elite Pharmaceuticals, Inc. ("Elite" or the Company") (AMEX: ELI) has successfully completed a second pilot Phase I...

Drug Store News - New delivery systems advance pain management medications

April 21, 2008 -- Advances in the pharmaceutical industry regarding pain management have made life easier for people living with chronic pain and have provided relief...

Business Wire - IMPAX to Reinitiate Sales of Limited Quantity of Generic OxyContin

November 27, 2007 -- HAYWARD, Calif. -- IMPAX Laboratories, Inc. (OTC:IPXL) today announced that its distributor DAVA Pharmaceuticals will reinitiate sales of a limited...

Inspection Monitor - Noramco clears audit with minor verbal observations on GMP training, prep procedures

September 1, 2007 -- Noramco, Athens, GA, Atlanta, GA, District Noramco, an API manufacturer based in Athens, GA, received some EIR observations from FDA during a 2006...


Drugs By Name
Drugs By Manufacturer
Partners
The following health oriented websites are recommended:
> Drug Topics
> Health Topics
> HGH Doctor
> HGH News
> Medaus Compounding Center
> Performance Enhancing Drugs
> Personal Trainer Search
> Testosterone News

Destinations
The following on-site destinations recommended:
> Anti-Aging
> Anti-Aging Books
> Anti-Aging Feeds
Site Tree | Disclaimer
Link Index | Resources | More Resources
What is Anti-Aging, Anti-Ageing or Antiaging?
Compounding Pharmacy | HGH News | Personal Trainer Search | AAR Dir | Health Topics | OOF CMS v3.5
© Copyright 2003- Odin Metatech, Inc, All Rights Reserved. Copyright violations will be prosecuted to the fullest extent of the law. Why plagerize? Use our free RSS feeds for syndication.
We are not affiliated with the American Academy for Anti-Aging Medicine (A4M)

Powered by Odin Assemble v2.0